AzTrials
AzTrials

UrolithiasisNCT07566741

A Prospective Analysis of Thulium Fiber Laser Efficiency

A study testing thulium fiber laser lithotripsy in people with Urolithiasis, run by Bozok University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Patients diagnosed with urolithiasis will be prospectively enrolled in this study. Preoperative diagnostic assessment will be performed using computed tomography (CT). Key parameters, including stone dimensions, quantity, total stone burden, and stone density (Hounsfield units), will be evaluated preoperatively. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Urolithiasis
What is being tested?
thulium fiber laser lithotripsy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
61 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jun 2025to 31 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • aged 18 years and above
  • diagnosed with symptomatic urinary system stones
  • planned URS or fURS
  • normal upper urinary tract anatomy
  • achieved stone-free

Who cannot join

  • active urinary tract infection
  • history of surgery/DJ stent placement within the last six months
  • congenital renal anomalies
  • patients with residual fragments on postoperative evaluation

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Yozgat Bozok University Faculty of Medicine

    Yozgat, Yozgat, 66100

Other trials in Turkey (Türkiye)

About this study

Official title: A Prospective Analysis of Thulium Fiber Laser Efficiency: How Stone Volume and Density Predict Intraoperative Energy Consumption

Patients diagnosed with urolithiasis will be prospectively enrolled in this study. Preoperative diagnostic assessment will be performed using computed tomography (CT). Key parameters, including stone dimensions, quantity, total stone burden, and stone density (Hounsfield units), will be evaluated preoperatively. This study aims to analyze data from patients who undergo ureteroscopic Thulium Fiber Laser (TFL) lithotripsy and achieve a stone-free status within a single procedural session. Based on these data, a 'Specific Energy Coefficient' will be derived to enable the preoperative prediction of the total laser energy required for successful lithotripsy.

Read the detailed description

This prospective observational trial investigated the correlation between Thulium Fiber Laser (TFL) energy consumption and stone characteristics. Adult patients (≥18 years) with symptomatic urinary stones indicated for (f)URS and normal upper tract anatomy were included. Only patients achieving a complete stone-free status in a single session were analyzed. Exclusion criteria comprised active urinary tract infection, history of ipsilateral surgery or stent placement within six months, congenital renal anomalies, and postoperative residual fragments. Stone parameters were evaluated via non-contrast computed tomography (NCCT, 1.0 mm slice thickness). Mean stone density was measured in Hounsfield Units (HU) using a representative region of interest (ROI). Stone volume (V) was calculated using the validated ellipsoid formula. Procedures were performed by two high-volume endourologists using a 200 µm Thulium fiber. Semirigid URS (7.5-9.5 F) or flexible URS (7.5 F) with an access sheath (10/12-12/14 F) were utilized based on stone location. All cases employed "Dusting Mode" (0.1-0.2 J; 80-150 Hz). Laser ablation time was recorded from the initial firing until complete visual stone clearance/dusting. The primary outcome was the derivation of the Specific Energy Coefficient, calculated by dividing the total energy by the product of stone volume and density. Data were analyzed using SPSS v26.0. Normality was assessed via Shapiro-Wilk/Kolmogorov-Smirnov tests. Descriptive data were reported as mean ± standard deviation or median. Spearman's correlation and Multiple Linear Regression were used to identify independent predictors of laser energy requirements, with the model's predictive power reported as adjusted R2. Statistical significance was set at p < 0.05.

Conditions
Urolithiasis
Being tested
thulium fiber laser lithotripsy
Keywords
urolithiasis, thulium fiber laser, lithotripsy, steno-free, energy
Medical subject headings
Urolithiasis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • thulium fiber laser lithotripsyProcedure or surgery

    Procedures were performed by two high-volume experienced endourologists. Semirigid URS (7.5-9.5 F) was utilized for ureteral stones, while flexible URS (7.5 F) with a ureteral access sheath (10/12 F or 12/14 F) was preferred for renal stones. A 200 µm Thulium fiber was employed in all cases. Fragmentation was performed in Dusting Mode (Pulse Energy: 0.1-0.2 J, Frequency: 80-150 Hz).

Study groups in NCT07566741
Study groupRoleWhat they receive
Stone-freeExperimentalNot described
Receives: Procedure: thulium fiber laser lithotripsy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. thulium fiber laser energy consumption per mm3xHu

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 May 2026
  2. Study start1 Jun 2025
  3. Primary completion31 Jan 2026
  4. Study completion31 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
61 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07566741
Sponsor's protocol ID
2025-GOKAEK-2513
Status last verified
May 2026
First submitted
28 Apr 2026
Last updated
8 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Selmi V, Oztekin U, Caniklioglu M, Isikay L. Prediction of The Energy Required for Ho:YAG Laser Lithotripsy of Urinary Stones. Urol J. 2021 Apr 28;18(3):284-288. doi: 10.22037/uj.v18i.6442.

    PubMed 33931845

Questions about this trial

What is this clinical trial studying?

A study testing thulium fiber laser lithotripsy in people with Urolithiasis, run by Bozok University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

thulium fiber laser energy consumption per mm3xHu (time frame: 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07566741, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in